CGX-1007 | m-entrepreneurship.com

Product Name :
CGX-1007

Search keywords :
Conantokin G

drugId :
null

Target Vo:
Glutamate [NMDA] receptor subunit epsilon 2

Target Vo Short Name :
NMDAR2B

Moa_Name:
Glutamate [NMDA] receptor subunit epsilon 2 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Precipio

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Epilepsy

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
SUMO1 Antibody (YA046)
FMRP Antibody
DRD2 Antibody: DRD2 Antibody is an unconjugated, approximately 51 kDa, rabbit-derived, anti-DRD2 polyclonal antibody. DRD2 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in rat, and predicted: human, mouse background without labeling.

Author: Betaine hydrochloride

Related Posts